Related Experiment Video
Updated: May 2, 2026

Monitoring the Assembly of a Secreted Bacterial Virulence Factor Using Site-specific Crosslinking
Published on: December 17, 2013
Molecular analysis of the interaction between staphylococcal virulence factor Sbi-IV and complement C3d
Ronald D Gorham1, Wilson Rodriguez1, Dimitrios Morikis1
1Department of Bioengineering, University of California, Riverside, California.
Computational simulations reveal the primary binding mode of Staphylococcus aureus Sbi-IV to complement C3d is more stable and physiologically relevant. This finding aids in designing new complement-targeting therapeutics.
Area of Science:
- Microbiology
- Immunology
- Structural Biology
Background:
- Staphylococcus aureus utilizes virulence factors for immune evasion.
- The staphylococcal immunoglobulin binding (Sbi) protein interacts with complement component 3 (C3) and its fragments (C3d).
- Two potential binding modes of Sbi domain IV (Sbi-IV) to C3d exist, but the physiological relevance is uncertain.
Purpose of the Study:
- To computationally investigate the interaction between C3d and Sbi-IV.
- To determine the physiologically relevant binding mode of Sbi-IV to C3d.
Main Methods:
- Molecular dynamics (MD) simulations to assess binding robustness.
- Brownian dynamics and steered MD simulations to analyze association kinetics and interaction stability.
Main Results:
- The first binding mode (PDB: 2WY8) demonstrated greater robustness with persistent polar/nonpolar interactions and conserved surface area compared to the second mode (PDB: 2WY7).
- The first binding mode exhibited faster association kinetics and more stable intermolecular interactions.
- The study confirms the first binding mode as the likely physiological interaction between Sbi-IV and C3d/C3.
Conclusions:
- The first binding mode of Sbi-IV to C3d is confirmed as the physiologically relevant interaction.
- While less stable, the second binding mode may also have a physiological role.
- Both identified binding sites can inform the structure-based design of novel complement therapeutics.
More Related Videos
12:27Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
Published on: January 3, 2020
09:03Multiplex PCR Assay for Typing of Staphylococcal Cassette Chromosome Mec Types I to V in Methicillin-resistant Staphylococcus aureus
Published on: September 5, 2013
Related Concept Videos
Complement System
Regulation of Bacterial Virulence
Staphylococcal Skin Infections